
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/3-MeO-PCP: Difference between revisions
Jump to navigation
Jump to search
>Unity No edit summary |
>Unity No edit summary |
||
Line 62: | Line 62: | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration=[[Oral min total time:: | |OralROA_Duration=[[Oral min total time::5]] - [[Oral max total time::8]] [[Oral total time units::hours]] | ||
|OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::90]] [[Oral onset time units::minutes]] | |OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::90]] [[Oral onset time units::minutes]] | ||
|OralROA_Comeup=[[Oral min comeup time::45]] - [[Oral max comeup time::90]] [[Oral comeup time units::minutes]] | |OralROA_Comeup=[[Oral min comeup time::45]] - [[Oral max comeup time::90]] [[Oral comeup time units::minutes]] | ||
|OralROA_Peak=[[Oral min peak time:: | |OralROA_Peak=[[Oral min peak time::2]] - [[Oral max peak time::3]] [[Oral peak time units::hours]] | ||
|OralROA_Offset=[[Oral min offset time::2]] - [[Oral max offset time::3]] [[Oral offset time units::minutes]] | |OralROA_Offset=[[Oral min offset time::2]] - [[Oral max offset time::3]] [[Oral offset time units::minutes]] | ||
|OralROA_Aftereffects=[[Oral min afterglow time::6]] - [[Oral max afterglow time::48]] [[Oral afterglow time units::hours]] | |OralROA_Aftereffects=[[Oral min afterglow time::6]] - [[Oral max afterglow time::48]] [[Oral afterglow time units::hours]] | ||
Line 73: | Line 73: | ||
|InsufflatedROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. | |InsufflatedROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. | ||
|InsufflatedROA_Bioavailability= | |InsufflatedROA_Bioavailability= | ||
|InsufflatedROA_Threshold=[[Insufflated threshold dose::1]] - | |InsufflatedROA_Threshold=[[Insufflated threshold dose::1]] - [[Insufflated dose units::2]] mg | ||
|InsufflatedROA_Light=[[Insufflated min light dose::2]] - [[Insufflated max light dose::5]] mg | |InsufflatedROA_Light=[[Insufflated min light dose::2]] - [[Insufflated max light dose::5]] mg | ||
|InsufflatedROA_Common=[[Insufflated min common dose::5]] - [[Insufflated max common dose::10]] mg | |InsufflatedROA_Common=[[Insufflated min common dose::5]] - [[Insufflated max common dose::10]] mg |
Revision as of 01:47, 11 January 2017
SubstanceBox/3-MeO-PCP | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common names | 3-MeO-PCP, Methoxyphencyclidine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 3-Methoxyphencyclidine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systematic name | 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Psychoactive class | Dissociative | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemical class | Arylcyclohexylamine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
- ↑ 1.0 1.1 3-MeO-PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential